Lipids

Lipids are small, organic molecules, that are usually hydrophobic or amphiphillic. For example, this group includes fats, fatty acids, waxes, triglycerides, sterols and phospholipids. Lipids are the main structural component of biological membranes of all cells. As such, bacterial lipid structures and glycolipids can serve as pathogen-associated molecular patterns (PAMPs) and are recognized by the human immune system. Various lipids and lipid complexes of bacterial origin are therefore used as immunostimulants.

Lipids are small,  organic molecules, that are usually hydrophobic or amphiphillic. For example, this group includes fats, fatty acids, waxes, triglycerides, sterols and phospholipids.... read more »
Close window
Lipids

Lipids are small, organic molecules, that are usually hydrophobic or amphiphillic. For example, this group includes fats, fatty acids, waxes, triglycerides, sterols and phospholipids. Lipids are the main structural component of biological membranes of all cells. As such, bacterial lipid structures and glycolipids can serve as pathogen-associated molecular patterns (PAMPs) and are recognized by the human immune system. Various lipids and lipid complexes of bacterial origin are therefore used as immunostimulants.

290 from 348 pages
No results were found for the filter!
D159687
D159687

Item number: Cay38778-10

D159687 is a negative allosteric modulator of phosphodiesterase 4D (PDE4D, IC50 = 28 nM for the human enzyme). It is selective for PDE4D over PDE4B (IC50 = 562 nM for the human enzyme), as well as 14 other PDE isoforms (IC50s = >1.4 µM). D159687 decreases forskolin-induced cAMP hydrolysis in HEK293 cells (IC50 = 253...
Keywords: N-[4-[(3'-chloro-6-methoxy[1,1'-biphenyl]-3-yl)methyl]phenyl]-urea
Application: Negative allosteric PDE4D modulator
CAS 1155877-97-6
MW: 366.8 D
From 91.00€ *
Review
CL4F8-6
CL4F8-6

Item number: Cay38802-1

CL4F8-6 is an ionizable cationic lipid (pKa = 6.14) that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). Intravenous administration of LNPs containing CL4F8-6 and encapsulating an mRNA reporter accumulate specifically in the mouse liver. LNPs containing CL4F8-6 and...
Keywords: 7-(4-(dipropylamino)butyl)-7-hydroxytridecane-1,13-diyl bis(2-hexyloctanoate)
Application: Ionizable cationic lipid, LNP formation
CAS 2766493-12-1
MW: 808.4 D
From 118.00€ *
Review
Lipid 23
Lipid 23

Item number: Cay38862-10

Lipid 23 is an ionizable cationic amino lipid (pKa = 5.7) that has been used with other lipids in the formulation of lipid nanoparticles (LNPs). Intravenous administration of LNPs containing lipid 23 and encapsulating an mRNA reporter accumulate specifically in the mouse liver.Formal Name:...
Keywords: 8-((2-((4-(dimethylamino)butanoyl)oxy)ethyl)(10-oxo-10-(tridecan-7-yloxy)decyl)amino)octyl 2-hexyldecanoate
Application: Ionizable cationic amino lipid, LNP formation
MW: 893.5 D
From 556.00€ *
Review
Dimethyldimyristylammonium (bromide)
Dimethyldimyristylammonium (bromide)

Item number: Cay38870-1

Dimethyldimyristylammonium is a cationic lipid that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). Administration of LNPs containing dimethyldimyristylammonium and encapsulating mRNA encoding a luciferase reporter increase fluorescence in HeLa cells.Formal Name:...
Keywords: Dimethylditetradecylammonium, N,N-dimethyl-N-tetradecyl-1-tetradecanaminium, monobromide
Application: Cationic lipid, LNP formation
CAS 68105-02-2
MW: 518.7 D
From 40.00€ *
Review
Tauro-Obeticholic Acid (sodium salt)
Tauro-Obeticholic Acid (sodium salt)

Item number: Cay38878-1

Tauro-obeticholic acid is an active metabolite of obeticholic acid, which is a farnesoid X receptor (FXR) agonist and semisynthetic derivative of chenodeoxycholic acid (Cay-10011286). Tauro-obeticholic acid is formed from obeticholic acid by taurine conjugation in the liver but can be reconverted back to obeticholic...
Keywords: Obeticholic Acid Taurine Conjugate, Tauro-6-Ethyl-CDCA, Tauro-6-Ethylchenodeoxycholic Acid, Tauro-OCA, T-ECDCA,...
Application: Obeticholic acid active metabolite, choleretic
CAS 2278141-79-8
MW: 549.7 D
From 251.00€ *
Review
RM 133-3
RM 133-3

Item number: Cay38917-10

RM 133-3 is an ionizable cationic lipid that has been used in the formation of lipid nanoparticles (LNPs) for the delivery of mRNA in vivo. LNPs containing RM 133-3 and encapsulating mRNA encoding human erythropoietin (EPO) increase serum human EPO protein levels in mice.Formal Name:...
Keywords: (9Z,9'Z)-((3,3'-((3-(diethylamino)propyl)azanediyl)bis(propanoyl))bis(oxy))bis(octadec-9-ene-18,7-diyl)...
Application: Ionizable cationic lipid, LNP formation
CAS 2941228-90-4
MW: 1376.2 D
From 391.00€ *
Review
(±)7(S),8(R)-EDT
(±)7(S),8(R)-EDT

Item number: Cay38933-100

(±)7(S),8(R)-EDT is an oxylipin.Formal Name: (2R,3S)-rel-3-(2Z,5Z,8Z)-2,5,8-tetradecatrien-1-yl-2-oxiranehexanoic acid. CAS Number: 355016-21-6. Synonyms: (±)-Dihomo-7(S),8(R)-EET, (±)7(S),8(R)-EpDoTrE. Molecular Formula: C22H36O3. Formula Weight: 348.5. Purity: >95%. Formulation: (Request formulation change), A...
Keywords: 7,8-EpDoTrE, 7,8-Epoxydocosatrienoic Acid, Dihomo-7,8-EET, 3-(2Z,5Z,8Z)-2,5,8-tetradecatrien-1-yl-2-oxiranehexanoic acid
Application: Adrenic acid metabolite, oxylipin
CAS 355016-21-6
MW: 348.5 D
From 76.00€ *
Review
p-methyl-N-salicyloyl Tryptamine
p-methyl-N-salicyloyl Tryptamine

Item number: Cay38958-10

p-methyl-N-salicyloyl Tryptamine is a neuroprotective agent and derivative of N-salicyloyl tryptamine. It reduces LPS-induced nitric oxide (NO) production in C6 rat glioma cells and BV-2 mouse microglia (IC50s = 7.48 and 4.94 µM, respectively). It also reduces LPS-induced production of TNF-alpha and prostaglandin E2...
Keywords: para-methyl-N-salicyloyl Tryptamine, LZWL02003, 2-hydroxy-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-benzamide
Application: Neuroprotective agent
CAS 1371564-45-2
MW: 294.4 D
From 85.00€ *
Review
13(Z)-Docosenoic Acid (sodium salt)
13(Z)-Docosenoic Acid (sodium salt)

Item number: Cay38975-10

13(Z)-Docosenoic acid is a 22-carbon monounsaturated fatty acid. Dietary administration of 13(Z)-docosenoic acid (6.6% w/w) increases weight gain and heart triglyceride levels in calcium-deprived weanling rats.CAS Number: 14488-85-8. Synonyms: C22:1(13Z), C22:1 n-9, cis-13-Docosenoic Acid, Erucic Acid, FA 22:1,...
Keywords: cis-13-Docosenoic Acid, C22:1 n-9, C22:1(13Z), Erucic Acid, Sodium Erucate
Application: 22-carbon monounsaturated fatty acid
CAS 14488-85-8
MW: 360.6 D
From 47.00€ *
Review
DORI
DORI

Item number: Cay38981-1

DORI is a cationic lipid that has been used in the formation of liposomes for the delivery of plasmid DNA in vitro.Formal Name: N-(2-hydroxyethyl)-N,N-dimethyl-2,3-bis[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]-1-propanaminium, monobromide. CAS Number: 153312-59-5. Synonyms: 1,2-Dioleoyl-3-dimethyl-hydroxyethylammonium...
Keywords: 1,2-Dioleoyl-3-dimethyl-hydroxyethylammonium bromide,...
Application: Cationic lipid, LNP formation
CAS 153312-59-5
MW: 773 D
From 42.00€ *
Review
1,2-Distearoyl-sn-glycero-3-PC (solution)
1,2-Distearoyl-sn-glycero-3-PC (solution)

Item number: Cay39189-1

1,2-Distearoyl-sn-glycero-3-PC is a phospholipid containing stearic acid (Cay-10011298) at the sn-1 and sn-2 positions. It has commonly been used in the generation of micelles, liposomes, and other types of artificial membranes.Formal Name: 1,2-distearoyl-sn-glycero-3-phosphatidylcholine. CAS Number: 816-94-4....
Keywords: 1,2-Distearoyl-sn-glycero-3-Phosphocholine, 1,2-DSPC, 18:0/18:0-PC, Coatsome MC 8080, PC(18:0/18:0),...
Application: Phospholipid, micelle/liposome formation
CAS 816-94-4
MW: 790.2 D
From 62.00€ *
Review
Lipid III-45
Lipid III-45

Item number: Cay39243-10

Lipid III-45 is an ionizable cationic lipid (pKa = 6.25). It has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA in vivo. LNPs containing lipid III-45 and encapsulating a luciferase mRNA reporter accumulate in liver and adipose tissue in mice. LNPs containing lipid III-45 have been...
Keywords: Cationic Lipid A, 2-butyl-octanoic acid, 1,1'-[[(3-hydroxypropyl)imino]di-9,1-nonanediyl] ester
Application: Ionizable cationic lipid, LNP formation
CAS 2096984-25-5
MW: 724.2 D
From 205.00€ *
Review
290 from 348 pages